Royal Marsden Sutton Hospital

At The Royal Marsden we have the expertise, facilities and technology to provide the highest standards of personalised care and the latest treatments for cancer patients. As Europe’s largest cancer centre we treat over 50,000 patients with various cancer types each year. With 2,500 specialist healthcare professionals working together to provide the best possible care and outcomes for patients, we are one of the only private providers to hold weekly multidisciplinary team meetings in each tumour specialty. Here, up to 35 cancer specialists, including surgeons, oncologists, radiologists, pathologists, nurses and many more, meet to discuss each individual case in detail before developing a tailored treatment plan for each patient. Our dedicated nursing and support teams are essential to our patients’ experience. We have 60 Clinical Nurse Specialists – a role The Royal Marsden pioneered – to provide 24/7 support to patients and help them cope with the physical, psychological and practical realities of cancer diagnosis and treatment. We have been innovators in cancer care for over 150 years, and together with our academic partner, The Institute of Cancer Research (ICR), we have developed, pioneered and discovered techniques and treatments that are now standard practice throughout the world. In surgery, we are able to offer the latest techniques to improve outcomes and reduce recovery times. We were the first centre in England to offer two types of robotic surgery – the da Vinci S and da Vinci Xi – revolutionary systems offering patients minimally invasive surgery that can reduce the amount of time they have to stay in hospital. We are the only centre in the UK to offer Isolated Limb Profusion surgery for sarcoma and melanoma patients; a technique which can be used to deliver a high dose of anti-cancer drugs to tumours which can’t be treated with traditional procedures and can mean that the patient avoids having a limb amputated. We are the largest radiotherapy centre in the UK, delivering over 75,000 radiotherapy treatments on 11 linear accelerators every year. In 2017 we will become the first centre in the UK to deliver MR Linac radiotherapy, a revolutionary new system that combines MRI imaging and targeted radiotherapy to minimise damage to healthy tissue. Choosing where to be treated for cancer is one of the most important decisions in a person’s life. The Royal Marsden combines the world’s leading experts with the latest technology to give our patients the best possible outcomes.